Blocking high-fat diet-induced obesity, insulin resistance and fatty liver by overexpression of Il-13 gene in mice

International Journal of Obesity

Volumn 39, Issue 8, 2015, Pages 1292-1299

  Darkhal, P ^a   Gao, M ^a   Ma, Y ^a   Liu, D ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD68 ANTIGEN; F4 80 PROTEIN; GLUCOSE; GREEN FLUORESCENT PROTEIN; INSULIN; INTERLEUKIN 13; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PLASMID DNA; PROTEIN; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 1;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BODY WEIGHT; CELL INFILTRATION; CONTROLLED STUDY; DIET INDUCED OBESITY; ENERGY EXPENDITURE; ENERGY METABOLISM; FAT MASS; FATTY LIVER; FOOD INTAKE; GENE TARGETING; GENE THERAPY; GENE TRANSFER; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; HISTOCHEMISTRY; HYDRODYNAMICS; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LEAN BODY WEIGHT; LIPID ANALYSIS; LIPID DIET; LIPID LIVER LEVEL; MACROPHAGE; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WEIGHT GAIN; WHITE ADIPOSE TISSUE; ANIMAL; C57BL MOUSE; DISEASE MODEL; LIVER; METABOLISM; OBESITY; PATHOLOGY;

ANIMALIA; MUS;

ADIPOSE TISSUE; ANIMALS; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; FATTY LIVER; INFLAMMATION; INSULIN RESISTANCE; INTERLEUKIN-13; LIVER; MICE; MICE, INBRED C57BL; OBESITY; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84938746413     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2015.52     Document Type: Article

References (34)

1. Caprio S, Daniels SR, Drewnowski A, Kaufman FR, Palinkas LA, Rosenbloom AL et al. Influence of race, ethnicity, and culture on childhood obesity: implications for prevention and treatment. Obesity 2008; 16: 2566-2577
2. Malik VS, Willett WC, Hu FB. Global obesity: trends, risk factors and policy implications. Nat Rev Endocrinol 2013; 9: 13-27
3. Zimmet P, Alberti K, Shaw J. Global and societal implications of the diabetes epidemic. Narure 2001; 414: 728-787
4. Sun K, Kusminski CM, Scherer PE. Adipose tissue remodeling and obesity. J Clin Invest 2011; 121: 2094-2101
5. Nishimura S, Manabe I, Nagai R. Adipose tissue inflammation in obesity and metabolic syndrome. Discov Med 2009; 8: 55-60
6. Fujisaka S, Usui I, Bukhari A, Ikutani M, Oya T, Kanatani Y et al. Regulatory mechanisms for adipose tissue M1 and M2 macrophages in diet-induced obese mice. Diabetes 2009; 58: 2574-2582
7. Wentworth JM, Naselli G, Brown WA, Doyle L, Phipson B, Smyth GK et al. Pro-inflammatory CD11c+CD206+ adipose tissue macrophages are associated with insulin resistance in human obesity. Diabetes 2010; 59: 1648-1656
8. Wu D, Molofsky AB, Liang HE, Ricardo-Gonzalez RR, Jouihan HA, Bando JK et al. Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science 2011; 332: 243-247
9. Sica A, Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J Clin Invest 2012; 122: 787-795
10. Stanya KJ, Jacobi D, Liu S, Bhargava P, Dai L, Gangl MR et al. Direct control of hepatic glucose production by interleukin-13 in mice. J Clin Invest 2013; 123: 261-271
11. Nguyen KD, Qiu Y, Cui X, Goh YP, Mwangi J, David T et al. Alternatively activated macrophages produce catecholamines to sustain adaptive thermogenesis. Nature 2011; 480: 104-108
12. Qiu Y, Nguyen KD, Odegaard JI, Cui X, Tian X, Locksley RM et al. Eosinophils and type 2 cytokine signaling in macrophages orchestrate development of functional beige fat. Cell 2014; 157: 1292-1308
13. Cardilo-Reis L, Gruber S, Schreier SM, Drechsler M, Papac-Milicevic N, Weber C et al. Interleukin-13 protects from atherosclerosis and modulates plaque composition by skewing the macrophage phenotype. EMBO Mol Med 2012; 4: 1072-1086
14. Ji Y, Sun S, Xu A, Bhargava P, Yang L, Lam KS et al. Activation of natural killer T cells promotes M2 macrophage polarization in adipose tissue and improves systemic glucose tolerance via interleukin-4 (IL-4)/STAT6 protein signaling axis in obesity. J Biol Chem 2012; 287: 13561-13571
15. Wynn TA. IL-13 effector functions. Annu Rev Immunol 2003; 21: 425-456
16. Kanneganti T-D, Dixit VD. Immunological complications of obesity. Nat Immunol 2012; 13: 707-712
17. Liu F, Song Y, Liu D. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Therapy 1999; 6: 1258-1266
18. Zhang G, Budker V, Wolff JA. High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. Hum Gene Ther 1999; 10: 1735-1737
19. Watanabe C, Seino Y, Miyahira H, Yamamoto M, Fukami A, Ozaki N et al. Remodeling of hepatic metabolism and hyperaminoacidemia in mice deficient in proglucagon-derived peptides. Diabetes 2012; 61: 74-84
20. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes care 2004; 27: 1487-1495
21. Folch J, Lees M, Sloane-Stanley G. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957; 226: 497-509
22. Ye J. Mechanisms of insulin resistance in obesity. Front Med 2013; 7: 14-24
23. Alkhouri N, Gornicka A, Berk MP, Thapaliya S, Dixon LJ, Kashyap S et al. Adipocyte apoptosis, a link between obesity, insulin resistance, and hepatic steatosis. J Biol Chem 2010; 285: 3428-3438
24. Feng B, Jiao P, Nie Y, Kim T, Jun D, van Rooijen N et al. Clodronate liposomes improve metabolic profile and reduce visceral adipose macrophage content in diet-induced obese mice. PLoS One 2011; 6: e24358
25. Gastaldelli A, Baldi S, Pettiti M, Toschi E, Camastra S, Natali A et al. Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study. Diabetes 2000; 49: 1367-1373
26. Hou CH, Hung L-M, Huang J-P. Exploring the non-alcoholic fatty liver disease pathogenesis mechanisms in high fat and high fructose diet fed rat (649.3). FASEB J 2014; 28: 3
27. Bu L, Gao M, Qu S, Liu D. Intraperitoneal injection of clodronate liposomes eliminates visceral adipose macrophages and blocks high-fat diet-induced weight gain and development of insulin resistance. AAPS J 2013; 15: 1001-1011
28. Gao M, Zhang C, Ma Y, Bu L, Yan L, Liu D. Hydrodynamic delivery of mIL10 gene protects mice from high-fat diet-induced obesity and glucose intolerance. Mol Ther 2013; 21: 1852-1861
29. Kamei N, Tobe K, Suzuki R, Ohsugi M, Watanabe T, Kubota N et al. Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance. J Biol Chem 2006; 281: 26602-26614
30. Farmer DG, Ke B, Shen XD, Kaldas FM, Gao F, Watson MJ et al. Interleukin-13 protects mouse intestine from ischemia and reperfusion injury through regulation of innate and adaptive immunity. Transplantation 2011; 91: 737-743
31. Zhu C, Zhang A, Huang S, Ding G, Pan X, Chen R. Interleukin-13 inhibits cytokines synthesis by blocking nuclear factor-kappaB and c-Jun N-terminal kinase in human mesangial cells. J Biomed Res 2010; 24: 308-316
32. Cho CH, Koh YJ, Han J, Sung HK, Jong Lee H, Morisada T et al. Angiogenic role of LYVE-1-positive macrophages in adipose tissue. Circ Res 2007; 100: e47-e57
33. Jiang H, Harris MB, Rothman P. IL-4/IL-13 signaling beyond JAK/STAT. J Allergy Clin Immunol 2000; 105: 1063-1070
34. Umeshita-Suyama R, Sugimoto R, Akaiwa M, Arima K, Yu B, Wada M et al. Characterization of IL-4 and IL-13 signals dependent on the human IL-13 receptor alpha chain 1: redundancy of requirement of tyrosine residue for STAT3 activation. Int Immunol 2000; 12: 1499-1509